Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders.

Quote
Commentary
Scorecard
Historical Prices
Chart
Stats
Ratios
Earnings/Growth Rates
Statements
SEC Filings

Featured Broker Partners

Home
About The Motley Fool
Fool Disclosure
Radio Show
Work at The Fool
Member Services

Advertise with The Fool
Privacy Policy
Email Subscriptions
RSS Headlines
Help
Site Map
Fool UK

Fool Friends:
Yahoo Finance
MSN Money
AOL Business News
Mint Personal Finance Software
lovemoney.com

BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions

266ms USEQ\EQWEBD12

Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA)

Sponsored Links

Featured Broker Partners